Golden Biotechnology Corporation 4132.TWO Stock
Golden Biotechnology Corporation Price Chart
Golden Biotechnology Corporation 4132.TWO Financial and Trading Overview
| Golden Biotechnology Corporation stock price | 29.1 TWD |
| Previous Close | 51.1 TWD |
| Open | 51.1 TWD |
| Bid | 50.8 TWD x 0 |
| Ask | 51.2 TWD x 0 |
| Day's Range | 50.6 - 51.3 TWD |
| 52 Week Range | 46.7 - 150.5 TWD |
| Volume | 226.56K TWD |
| Avg. Volume | 504.17K TWD |
| Market Cap | 7.3B TWD |
| Beta (5Y Monthly) | 0.886643 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.46 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4132.TWO Valuation Measures
| Enterprise Value | 7.17B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 33.495907 |
| Price/Book (mrq) | 9.542411 |
| Enterprise Value/Revenue | 32.921 |
| Enterprise Value/EBITDA | -27.777 |
Trading Information
Golden Biotechnology Corporation Stock Price History
| Beta (5Y Monthly) | 0.886643 |
| 52-Week Change | -63.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 150.5 TWD |
| 52 Week Low | 46.7 TWD |
| 50-Day Moving Average | 55.58 TWD |
| 200-Day Moving Average | 61.87 TWD |
4132.TWO Share Statistics
| Avg. Volume (3 month) | 504.17K TWD |
| Avg. Daily Volume (10-Days) | 268.5K TWD |
| Shares Outstanding | 142.23M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -124.81% |
| Operating Margin (ttm) | -136.24% |
| Gross Margin | 69.68% |
| EBITDA Margin | -118.52% |
Management Effectiveness
| Return on Assets (ttm) | -14.31% |
| Return on Equity (ttm) | -30.20% |
Income Statement
| Revenue (ttm) | 217.82M TWD |
| Revenue Per Share (ttm) | 1.53 TWD |
| Quarterly Revenue Growth (yoy) | 244.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -258168992 TWD |
| Net Income Avi to Common (ttm) | -271876992 TWD |
| Diluted EPS (ttm) | -1.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 523.48M TWD |
| Total Cash Per Share (mrq) | 3.68 TWD |
| Total Debt (mrq) | 284.54M TWD |
| Total Debt/Equity (mrq) | 37.21 TWD |
| Current Ratio (mrq) | 2.282 |
| Book Value Per Share (mrq) | 5.376 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -245903008 TWD |
| Levered Free Cash Flow (ttm) | -98846496 TWD |
Profile of Golden Biotechnology Corporation
| Country | Taiwan |
| State | N/A |
| City | New Taipei City |
| Address | No. 27-6, Zhongzheng E. Road |
| ZIP | 251 |
| Phone | 886 2 2808 6006 |
| Website | https://www.goldenbiotech.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Q&A For Golden Biotechnology Corporation Stock
What is a current 4132.TWO stock price?
Golden Biotechnology Corporation 4132.TWO stock price today per share is 29.1 TWD.
How to purchase Golden Biotechnology Corporation stock?
You can buy 4132.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Golden Biotechnology Corporation?
The stock symbol or ticker of Golden Biotechnology Corporation is 4132.TWO.
Which industry does the Golden Biotechnology Corporation company belong to?
The Golden Biotechnology Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Golden Biotechnology Corporation have in circulation?
The max supply of Golden Biotechnology Corporation shares is 142.23M.
What is Golden Biotechnology Corporation Price to Earnings Ratio (PE Ratio)?
Golden Biotechnology Corporation PE Ratio is now.
What was Golden Biotechnology Corporation earnings per share over the trailing 12 months (TTM)?
Golden Biotechnology Corporation EPS is -1.46 TWD over the trailing 12 months.
Which sector does the Golden Biotechnology Corporation company belong to?
The Golden Biotechnology Corporation sector is Healthcare.